PETER E. H ILSENRATH

CURRICULUM VITAE

PETER E. HILSENRATH

I. Personal Data Date of Preparation September 2020 A. Citizenship Status: U.S.

B. e mail [email protected] II. Education 1985 Ph.D. Economics University of Texas, Austin 1978 B.A. Environmental Studies & Economics University of California, Santa Cruz III. Academic Appointments

2020 - Professor Eberhardt School of Business, University of the Pacific, Stockton California 2009 - 2020 Joseph M. Long Chair in Eberhardt School of Business and Thomas Healthcare Management J. Long School of Pharmacy & Health & Professor of Economics Sciences, University of the Pacific Stockton, California 2007 - 2008 Professor & Interim Chair Department of Health Management

and Policy School of Public Health University of North Texas Health Science Center, Fort Worth

2002- 2007 Professor Department of Health Management

and Policy School of Public Health University of North Texas Health Science Center, Fort Worth

2000 – 2002 Associate Professor Department of Health Management

& Founding Chair and Policy School of Public Health University of North Texas Health Science Center, Fort Worth

1999 - 2000 Associate Professor Department of Health Management

2

& Policy College of Public Health The University of Iowa 1998 - 1999 Associate Professor Division of Health Management & Policy Department of Preventive Medicine & Environmental Health College of Medicine The University of Iowa

1997-1998 Assistant Professor Division of Health Management & Policy Department of Preventive Medicine and Environmental Health College of Medicine The University of Iowa

1991-1997 Assistant Professor Graduate Program in Hospital

& Health Administration College of Medicine The University of Iowa

1989-91 Faculty Associate Graduate Program in Hospital

& Health Administration College of Medicine The University of Iowa

1986 Lecturer Department of Economics

University of the Witwatersrand Johannesburg, South Africa

1982-85 Assistant Instructor Department of Economics

University of Texas Austin, Texas

1984 Assistant Lecturer Department of Economics University of the Witwatersrand Johannesburg, South Africa 1982, 1983 Associate Instructor Department of Economics University of California, Santa Cruz

3

IV. Other Employment Pertaining to Current Professional Appointments 1995-96 Chief Economist Syfrets Managed Assets Cape Town, South Africa 1986-89 Research Staff Center for Naval Analyses Alexandria, Virginia 1978-80 Operations Associate Lockheed Missiles & Space Co. Sunnyvale, California V. Professional Affiliations

Adjunct Research Professor, Center for International Health Services Research and Policy, Graduate Program in Health Policy and Administration, Washington State University, Spokane Healthcare Financial Management Association

International Health Economics Association Academy of Management American College of Healthcare Executives Lodi Memorial Hospital Association VI. Areas of Research Interest Cost Containment and Efficiency Health Finance Technology Assessment International Health Health Management Education

VII Current Projects South African economic history Graduate health management education Healthcare occupations outlook Retail pharmacy market structure and performance Cost accounting in hospital and healthcare management VIII. Teaching Activities Number Percent Registered Length Responsible University of California, Santa Cruz 1982 Basic Microeconomics 15 3 hrs. 100% 1983 Basic Microeconomics 15 3 hrs. 100% University of Texas, Austin 1982 Basic Macroeconomics 80 3 hrs. 100%

4

1983 Basic Microeconomics 80 3 hrs. 100% 1983 Basic Microeconomics 80 3 hrs. 100% 1985 Basic Macroeconomics 40 3 hrs. 100% 1985 Basic Microeconomics 35 3 hrs. 100% University of the Witwatersrand, Johannesburg 1984 Basic Microeconomics 75 3 hrs. 100% 1984 Basic Macroeconomics 75 3 hrs. 100% 1984 Resource & Energy Economics 15 3 hrs. 100% 1986 Resource & Energy Economics 15 3 hrs. 100% 1986 Basic Microeconomics 15 3 hrs. 100% The University of Iowa 1989 80:213 Health Economics 19 3 hrs. 100%

1990 80:212 Intermediate Microeconomics 12 3 hrs. 100%

1990 80:213 Health Economics 22 3 hrs. 100%

1990 80:217 Topics in Health Insurance 6 3 hrs. 100%

1991 80:280 Independent Study 1 3 hrs. 100%







1993 80:212 Health Economics I 16 3 hrs. 100%



1993 80:213 Health Economics II 23 3 hrs. 100%


5

1994 80:215 Managerial Finance 21 3 hrs. 100%








1997 141:118/ 129:115 Spring Colloquium: South Africa after Apartheid 25 3 hrs. 12%

1997 80:217 Health Ins & Managed Care 14 3 hrs. 100%



1998 80:220 Adv Tpcs in Managed Care 9 3 hrs. 50%





1999 90:266 Case Management 12 3 hrs. 12%

1999 80:155 US Hlth in Glbl Persp 7 3 hrs. 33%

1999 80:213 Health Economics II 13 3 hrs 100%

1999 80:170 Comp Hlth Systm: Russia, 3 3 hrs 100% E. Europe, and Eurasia

2000 80:220 Adv Tpcs in Managed Care 12 3 hrs 50%

2000 80:212 Health Economics I 15 1 hr 100% The University of North Texas Health Science Center

2000 PHPM 5145 Sem in PH: Health Econ 8 3 hrs 100%

2001 PHPM 5255 Finance for Health Mnmnt 5 3 hrs 100%

2001 HMAP 5245 Health Economics 13 3 hrs 100%

6

2002 HMAP 5255 Finance for Health Mnmnt 10 3 hrs 100%



2003 HMAP 5/6910 Health Ins & Managed Care 3 3 hrs. 100%



2004 HMAP 6215 Health Ins & Managed Care 5 3 hrs 100%


2005 HMAP 5255 Finance for Health Mnmnt 13 3 hrs 100% 2005 HMAP 6215 Health Ins & Managed Care 4 3 hrs 100% 2005 HMAP 5245 Health Economics 11 3 hrs 50%





2008 HMAP 5255 Health Finance I 6 3 hrs 50%

2008 HMAP 5270 Health Services Mnmnt 4 3 hrs 50%

The University of the Pacific

2009 BUSI 293B Healthcare Finance 4 3 hrs 100%

2009 BUSI 293C Int Health Care Systems 5 3 hrs 100%

2009 BUSI 293G Health Insurance 6 3 hrs 100%

2009 PRAC 101 Pharm Orientation 110 1 hr 3%

2010 BUSI 293B Healthcare Fin: Pharm apps 8 3 hrs 100%

2010 PRAC 149A Healthcare Fin: Pharm apps 3 3 hrs 100%

2010 BUSI 251 Int Healthcare Systems 6 3 hrs 100%


2011 BUSI 250 Health Finance: Health Ins 12 3 hrs 100%

7


2011 PRAC 140 Healthcare Fin: Pharm apps 4 3 hrs 100%






2013 PHRM 161 Pharm Mngmnt and Finance 210 2 hrs 42%





2014 BUSI 208 Managerial Economics 3 2 hrs 100%




2016 MBA S 293A Health Finance: Health Ins 7 3 hrs 100%



2018 Pacific Seminar II: American Health Care 16 4 hrs 100%





2018 BUSI 293 Ind Studies in Health Economics 4 1 hr 100%


2019 BUSI 213 Ethics & Corporate Social Resp 32 3 hrs 100%

2020 Pacific Seminar II: American Health Care 25 4 hrs 100%

8

2020 BUSI 213 Ethics & Corporate Social Resp 21 3 hrs 100%

2020 Pacific Seminar III: What is an Ethical Life? 30 3 hrs 100%

2020 Pacific Seminar III: What is an Ethical Life? 30 3 hrs 100%

IX. Teaching Activities (other than classroom or clinical)

University of Iowa Faculty Advisor to Students at University of Iowa and University of North Texas Health Science Center (1989 - 2009).

Member: Curriculum Committee Graduate Program in Hospital and Health Administration, University of Iowa (1991 - 1995). Field Studies Liaison Graduate Program in Hospital and Health Administration, University of Iowa (1992-1995). Continuing Medical Education Liaison Graduate Program in Hospital and Health Administration, University of Iowa, (1992-1995).

Director, Health Care Reform and Cost Control, Continuing Medical Education Course, University of Iowa, Iowa City, IA (1993).

Faculty Member, Global Health Studies, University of Iowa (1996-2000). Faculty Member, Center for Russian, East European and Eurasian Studies (CREEES), University

of Iowa (1996-2000). Faculty Member, African Studies, University of Iowa, (1996-2000). PACS workshop, University of the Pacific, (2019). University of North Texas Health Science Center

Organizer and Participant, Economics of Tuberculosis Surveillance and Treatment Workshop, University of North Texas Health Science Center at Fort Worth (2004). Organizer and Participant, Second Conference on the Economics of Tuberculosis Surveillance and Treatment Workshop, University of North Texas Health Science Center at Fort Worth (2005). Outstanding School of Public Health Teacher Award (2006). University of the Pacific Director, PharmD/MBA Program, University of the Pacific (since 2009). Track Director, MBA Concentration in Healthcare Management, University of the Pacific (Since 2009). Coordinator and Team Leader for PharmD/MBA trip to Washington DC to participate in Capitol Hill Event (RxImpact) organized by the National Association of Chain Drug Stores (NACDS) in 2009, 2010 and 2011. Team Leader for Pacific MBA contestants at the American College of Healthcare Executives annual College Bowl (since 2010).

9

Team member at Sacramento Capitol meeting with legislators advocating on behalf of the Valley Coalition for the UC Merced Medical School (2010). Interviewer of Pre-pharm applicants to the PharmD program at the University of the Pacific (2009-2012). The Affordable Care Act, Continuing Education Course for Saint Joseph’s Hospital, Stockton, October 2012. University of the Pacific Independent Studies, Preetpal Johal, PharmD student, Fall 2012. Provided primary draft of section of Accreditation Council for Pharmacy Education (ACPE) report on financial resources, September 2014. Faculty Advisor to PharmD students (since 2014).

X. Other Professional Activities

Current Editorial Boards Editorial Board for the International Journal of Pharmaceutical and Healthcare Marketing (since 2010). Editorial Board for the Journal of Primary Care and Community Health (since 2014). Editorial Board for the Journal of Health Care Finance (since 2014). Editorial Board for Inquiry: The Journal of Health Care Organization, Provision and Financing (since 2015). Editorial Board for Hospital Topics (since 2016). Previous Editorial Boards Editorial Board for the Journal of Health Administration Education (2013-2019). Editorial Board for The Journal of South African and American Comparative Studies (2000-2007). Editorial Board for Texas Journal of Rural Health (2002-2004). Editorial Board for the Public Health International Bulletin (2005-2007). Editorial Board for the Journal of Rural Health (2007-2014). Journal Reviewing Reviewer for the South African Journal of Economics (1984, 1986). Reviewer for Hospital and Health Services Administration (1989 – 1997). Reviewer for Journal of Health Care Management (1997, 2014). Reviewer for the Journal of Rural Health (since 1991). Reviewer for Health Services Research (1994). Reviewer for Health Care Financing Review (1999 - 2001). Reviewer for Journal of Social Behavior and Personality (1999).

10

Reviewer for The Journal of South African and American Comparative Studies (2000-2007). Reviewer for International Journal of Health Planning and Management (2002). Reviewer for the Texas Journal of Rural Health (2002-2004). Reviewer for the American Journal of Public Health (2004-2008). Reviewer for the Journal of Health Care for the Poor and Underserved (2007-2008). Reviewer for Academy of Management Annual Meeting Presentations (since 2009 - 2012). Reviewer for the Journal of Health Administration Education (since 2010). Reviewer for the Journal of Primary Care and Community Health (since 2011). Reviewer for the International Journal of Pharmaceutical and Healthcare Marketing (since 2011). Reviewer for Health Affairs (2013). Reviewer for Pharmacy (2013). Reviewer for Journal of Health Care Finance (since 2014). Reviewer for Inquiry: The Journal of Health Care Organization, Provision and Financing (since 2014). Reviewer for Hospital Topics (since 2016). Reviewer for Medical Care (2017). Reviewer for PLOS ONE (since 2017). Reviewer for Applied Economics (2019). Reviewer for BMC Health Services Research (2019). Reviewer for Health Services Research and Managerial Epidemiology (since 2019). Reviewer for Pharmacoeconomics (online) (2019). Reviewer for The Lancet (2020) Consulting Consultant to Meardon, Sueppel, Downer and Hayes, Iowa City (1991) This case involved providing background material on utilization review and how decisions to admit patients to the hospital are made in managed care. The purpose was support of a medical malpractice case. Consultant to Nicholas Critelli, Des Moines (1992). Provided expert opinion on restraint of trade involving a hospital and local physicians. Consultant and expert witness for Wildman, Harold, Allen and Dixon, Chicago (1994-96). Baxter International was faced with a complaint alleging tortuous interference in trade in disposable infusion pumps. Provided an estimate of economic damages. Consultant to the Representative Association of Medical Schemes (RAMS), Johannesburg, 1995. Consultant and expert witness for Wildman, Harold, Allen and Dixon, Chicago (1999). This was a medical malpractice case. Provided an estimate of "noneconomic" damages.

11

Consultant and expert witness for Shook, Hardy & Bacon, Kansas City (2001). This case was settled shortly after research began on a case involving a local hospital and a physician group. The issue was violation of agreements with no-compete clauses in local markets. Consultant and expert witness for Lewis, Rice and Fingersh, Kansas City (2002-2003). This case involved a small manufacturer (SizeWise) of bariatric beds and related equipment in a vertical restraint dispute with a medical supply distributor. Consultant and expert witness for Cotham, Harwell & Evans, Houston (2004) Antitrust case between a major insurer and a small group of OB-GYN physicians. Consultant for Schroeter, Goldmark & Bender, Seattle, Washington (2006) Analysis of possible induced demand for surgical services. Consultant for Lafont, Tunnell & Hamilton, Plainview, Texas (2006-2007) Estimate of direct and indirect medical costs and well as impairment costs using QALY methodology. Consultant for Wood, Smith, Henning & Berman LLP (2017-18) Assessment of market conditions impacting physicians over several decades. Consultant for Institute of Management (2018-19) Affidavit and other legal support regarding plagiarism and academic conduct. Consultant to Quebec Deposit and Investment Fund (2019) Provide perspectives regarding “Medical for All” and impact on US health insurance industry. Consultant to UBS (2020) Provide perspectives on economic and market impacts of coronavirus. External Promotion and Tenure Review External associate professor promotion and tenure review for Tom Xu. Department of Family and Community Medicine, Texas Tech University (2005). External professor promotion and tenure committee review for Joseph Coyne, Department of Health Policy and Management, Washington State University (2005). External associate professor promotion and tenure committee review for Tyrone Borders, Department of Health Policy and Management, University of Arkansas for Medical Sciences (2009). External associate professor promotion and tenure committee review for Tricia Johnson, Department of Health Systems Management, Rush University (2009). External associate professor promotion and tenure committee review for Alberto Coustasse, Lewis School of Business, Marshall University (2010). External professor promotion and tenure committee review for Jae Kennedy, Department of Health Policy and Management, Washington State University (2011). External promotion and tenure committee review for Ty Borders, Department of Health Services Management, University of Kentucky (2012). External associate professor promotion and tenure committee review for Jim Stimpson, Department of Health Services Research and Administration, University of Nebraska Medical Center (2012). External professor promotion and tenure committee review for Yufeng Li, Division of Preventive Medicine, University of Alabama at Birmingham (2014).

12

External associate professor promotion and tenure committee review for Fernando Wilson, Department of Health Services Research and Administration, University of Nebraska Medical Center (2015). External associate professor promotion and tenure committee review for Jennifer Schultz, Department of Organization and Management, University of Minnesota - Duluth (2015). External professor promotion and tenure committee review for Tricia Johnson, Department of Health Systems Management, Rush University (2015). External associate professor promotion and tenure committee review for Kevin Broom, Department of Health Policy & Management, Graduate School of Public Health, University of Pittsburgh (2017). External professor with tenure appointment for Ty Borders at University of Kansas and Florida State University (2017). Board of Directors Member: Board of Directors, Intertron Industries, Orange County, California (1999 - 2006). Member: Board of Directors, Philani Healthcare, Johannesburg, South Africa (2000-2002).

State and County Committees/Groups Member: Health Care Utilization Task Force, Health Data Commission of the State of Iowa (1990

91). Member, Texas Department of Health Hospital Preparedness Planning Committee (2002-2004)

Member, Texas Department of Health Obesity Study Group (2003-2008). Member, San Joaquin County Community Health Forum/ San Joaquin County Healthcare Leadership Council (2010 - 2019). Other Participant, Round Table Discussions at Johns Hopkins University School for International Studies on the Future of South Africa (1987). Speaker: University of Iowa Hospitals and Clinics Advanced Management Institute (1990) Speaker: University of Iowa Lipid Disorder Training Workshop (1990-92). Health Policy Advisor to Tom Harkin during presidential bid (1992). Member, Harris Health Exchange (2000-2003). Member, Texas/WHO Collaborating Center for Research and Training on Mental Health and Psychosocial Factors in Health (2001-2003).

Participant in planning for the Promotion/Disease Prevention and Health Care Delivery section for the National Board of Osteopathic Medical Education (NBOME) (2006-2007).

Participant in Focus Group meeting for the Executive Health Program at Harris Methodist Fort Worth Hospital (2006). Provider of questions for the National Board of Osteopathic Medical Examiners (2007).

13

Successful nomination of Biologics vs. Conventional Systemic Treatment for Moderate and Severe Psoriasis for Comparative Effectiveness review by the Effective Health Care Program of the Agency for Healthcare Research and Quality (2010). Track Chair at two sessions of the Sixth International Conference on Healthcare Systems (Gaziantep, Turkey) 2010 Track Chair at the Seventh International Conference on Global Business Issues and Healthcare Systems, Jaipor National University (Jaipor, India), January 2013.

Association of University Programs in Health Administration (AUPHA) International Health Administration Business Plan Group (2013-2014) Academic Futuring team participant. A working group exploring the university of the future consisting of staff of the architectural firm HOK, higher education experts with Cisco Systems and myself. Since February 2014.

California Association of Healthcare Leaders Board of Governors Exam Workshop, Finance Content Expert, Vacaville, California, March 2017.

Global Advisory Board for the Eleventh International Conference on Healthcare Systems and Global Business Issues at IMS Unison University, Dehradun India, January 2018.

XI. Collegiate, University, Local, State and National Committees

University of Iowa Member, Health and Development in Agrarian Societies (HADAS), University of Iowa (1989-92).

Departmental Blood Borne Pathogen Compliance Officer, University of Iowa (1992-95). Member, University of Iowa Global Studies Program Steering Committee (1996 -2000). Member, University of Iowa African Studies Program Steering Committee (1996 - 2000). Member, Continuing Education and Seminar Committee of the University of Iowa College of

Public Health (1997 - 2000). Member, University of Iowa Center for Russian, East European and Eurasian Studies Fellowship Selection Committee (1998 - 2000). Member, Review Committee for the University of Iowa MA in Third World Development Support (1999). University of North Texas Health Science Center Director, University of North Texas Institute for Public Health Research, Center for Health Management and Policy Research (2000 - 2005). University of North Texas School of Public Health Promotion and Tenure Committee (member 2000 – 2003 and Chair, 2003-2007). University of North Texas School of Public Health Executive Council (2000-2002).

University of North Texas School of Public Health Search Committee (2000-2001, 2004-2005, 2006-2007).

14

University of North Texas School of Public Health Faculty Development Committee (2000-2001). University of North Texas School of Public Health Admissions Committee (2000–2001). University of North Texas School of Public Health, Curriculum Committee for Council on Education in Public Health (CEPH) Accreditation (2000-2002). University of North Texas School of Public Health, Planning and Evaluation Committee (2006 - 2008). University of North Texas School of Public Health, Doctoral Studies Committee (2007-2008). University of North Texas Health Science Center Bylaws Committee (2001 -2007). University of North Texas Health Science Center Osteopathic Research Center Internal Advisory Committee (2002-2008). Planning Committee for the University of North Texas School of Public Health Building (2001). Indirect Cost Committee for the University of North Texas Health Science Center (2001-2008). Coordinator, CEPH Accreditation Document for the University of North Texas School of Public Health (2001). University of North Texas Health Science Center Intellectual Property Advisory Committee (2003 - 2006). University of North Texas Health Science Center Faculty Grievance Committee (2003-2008). Member, Association of Schools of Public Health Core Competency Development Committee, Health Policy and Management Working Group (2004-2006). University of North Texas Health Science Center School of Public Health Self Study for Accreditation, Co-Chair of Working Group 4- Faculty, Staff and Students (2005-2006). Chair, Faculty Search Committee, Department of Health Management and Policy, University of North Texas Health Science Center School of Public Health (2005-2006). Faculty Coordinator: MBA in Health Services Administration through the College of Business Administration at the University of North Texas at Denton (2005-2008). University of the Pacific University of the Pacific Graduate Council and Committee on Graduate Studies (2009-2010) and (2015-2016). University of the Pacific School of Pharmacy and Health Sciences Pharmacoeconomics, Health Outcomes and Services Track Advisory and Admissions Committee (since 2009). Search Committee Member, for Dean of the Eberhardt School of Business, University of the Pacific (2009-2010). Member - Valley Coalition for UC Merced Medical School (2009 - 2011). Member, Productivity and P&T Criterion Working Group, Thomas J. Long School of Pharmacy and Health Sciences (2010). Research Committee: Eberhardt School of Business (since 2010). AmerisourceBergen Entrepreneurial Pharmacy Practice Chair Search Committee (2011).

15

University of the Pacific Strategic Planning Committee member and writer: The Future of Human Health and Well Being (2011-2012). University of the Pacific Academic Council (Spring 2012). Search Committee Member, for finance faculty of the Eberhardt School of Business, University of the Pacific (2012-2013). Working group for AOL accreditation criteria (2012). University of the Pacific Academic Planning and Alignment Rating Team Participant for the Eberhardt School of Business (2014). Sacramento MBA Task Force Member (2014). Ad hoc advisor to Faculty Compensation Committee on health benefits (2014). Health Initiative Task Force to Provost – Future of Health Subcommittee (2015-2016). Coordinator for Healthcare Analytics MS (2016). Member of Academic Council (2018-2019, February). Member of Academic Affairs Committee on Undergraduate Studies (2016-2019). University Promotion and Tenure Committee (2018-2019). Graduate Admissions Committee, Eberhardt School of Business, (2010-2019).

XII. Financial Resources - Grants and Contracts

1. Title: "Benefit-Cost Analysis of Family Planning Services in Iowa" 2. Source: Iowa Family Planning Council 3. a. Annual direct funds: $15,000

b. Total direct funds: $15,000 4. Period of funding: 10/91-03/92 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 35%

b. Percent salary: 20% c. Role/contributions: Evaluation of public sector family planning expenditure.

Does the taxpayer save money by averting expenditures associated with unwanted pregnancy?

1. Title: "Economic Impact of Hospital Spending in the Quad-City Region" 2. Source: Greater Quad-City Hospital Council 3. a. Annual direct funds: $20,000

b. Total direct funds: $20,000 4. Period of funding: 01/92-07/92 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 30%

b. Percent salary: 20% c. Role/contributions: Analysis of multiplier effects in the Quad-Cities metropolitan area.

1. Title: "Cost-Effectiveness of Erythropoietin for Treatment of Anemia In Neonates"

16

2. Source: Ortho Biotech 3. a. Annual direct funds: $7,000

b. Total direct funds: $7,000 4. Period of funding: 06/92-05/93 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 20% b. Percent salary: 7% c. Role/contributions: Cost analysis of recombinant erythropoietin and blood transfusion compared with transfusions only in the case of anemic neonates. 1. Title: "Development of Health Management Education in South Africa" 2. Source: Midwest Universities Consortium for International Activities

3. a. Annual direct funds: $700 b. Total direct funds: $700 4. Period of funding: 12/92-01/93 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 2% b. Percent salary: 0% c. Role/contributions: Help develop health management education in South Africa.

1. Title: "International Health Project" 2. Source: United States Department of Education

3. a. Annual direct funds: $900 b. Total direct funds: $900 4. Period of funding: 01/93-05/93 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 10% b. Percent salary: 0% c. Role/contributions: Integrate competitive international health systems into curriculum 1. Title: "Improving the Quality of Rural Hospital ICU Care" 2. Source: Agency for Health Care Policy and Research

3. a. Annual direct funds: $242,958 (estimate) b. Total direct funds: $1,035,002

4. Period of funding: 06/01/93-11/30/97 5. Principal Investigator: John Fieselmann 6. a. Percent effort: 10% b. Percent salary: 10% c. Role/contributions: Evaluate costs of educational interventions. 1. Title: "National Laboratory for the Study of Rural Telemedicine" 2. Source: National Library of Medicine

3. a. Annual direct funds: $1,672,054 b. Total direct funds: $5,269,071

4. Period of funding: 04/01/94-12/31/97 5. Principal Investigator: Michael Kienzle 6. a. Percent effort: 1%

17

b. Percent salary: 5% c. Role/contributions: Help assess efficiency of emergency care with telemedicine. 1. Title: "Economic Impact of Hospital Spending in Iowa" 2. Source: Iowa Hospital Association

3. a. Annual direct funds: $26,750 b. Total direct funds: $26,750 4. Period of funding: 08/94-02/95 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 15% b. Percent salary: 0% c. Role/contributions: Analyze multiplier effects of hospital spending in Iowa. The study also looked at the stabilizing impact of hospital expenditures. 1. Title: "Health Policy as Fiscal Policy" 2. Source: Syfrets Managed Assets

3. a. Annual direct funds: $14,963 b. Total direct funds: $14,963 4. Period of funding: 07/96-06/97 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 10% b. Percent salary: 0% c. Role/contributions: Examine the role of stepped-up public health spending to generate jobs and economic growth. 1. Title: "Fiscal Constraints and Health Expenditures in South Africa" 2. Source: Midwest Universities Consortium for International Activities

3. a. Annual direct funds: $500 b. Total direct funds: $500 4. Period of funding: 12/96-01/97 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 2% b. Percent salary: 0%

c. Role/contributions: Analysis of public sector health spending in an environment of fiscal deficits.

1. Title: "National Resource Center for International and Comparative Studies: Russia, Eastern Europe and Eurasia"

2. Source: Department of Education 3. a. Annual direct funds: $163,678

b. Total direct funds: $494,154 4. Period of funding: 08/15/97-8/14/00 5. Principal Investigator: Steven Hoch 6. a. Percent effort: 25% b. Percent salary: 5-10% c. Role/contributions: Offer a course focusing on East European health care.

18

1. Title: "National Resource Center for International and Comparative Studies: Global Health Studies Program" 2. Source: Department of Education

3. a. Annual direct funds: $83,406 b. Total direct funds: $199,187 4. Period of funding: 08/15/97-08/14/00 5. Principal Investigator: Virginia Dominguez 6. a. Percent effort: 12% b. Percent salary: 5% c. Role/contributions: Participate in teaching course on contemporary health issues.

1. Title: "Comparative Health Care Systems: Russia and Eastern Europe "

2. Source: Midwest Universities Consortium for International Activities 3. a. Annual direct funds: $600

b. Total direct funds: $600 4. Period of funding: 12/97-1/98 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 2% b. Percent salary: 0% c. Role/contributions: Facilitate development of a course for The University of Iowa Center for Russian, East European and Eurasian Studies 1. Title: “Cost Analysis of the VIA Blood Gas Monitor” 2. Source: VIA Medical 3. a. Annual direct funds: $11,500 b. Total direct funds: $11,500 4. Period of funding: 11/98 – 4/99 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 20% b. Percent salary: 20% c. Role/contributions: Evaluate relative costs of electronic blood gas monitor relative to

more traditional laboratory analysis

1. Title: University Partnership: University of Natal 2. Source: Midwest Universities Consortium for International Activities

3. a. Annual direct funds: $600 b. Total direct funds: $600 4. Period of funding: 5/99-6/99 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 1% b. Percent salary: 0% c. Role/contributions: Participate in University Partnership and explore possibility of

Fulbright funding 1. Title: “Bariatric Beds and Related Equipment: An Antitrust Analysis” 2. Source: Lewis, Rice and Fingersh

19

3. a. Annual direct funds: $32,418 b. Total direct funds: $32,418 4. Period of funding: 9/02 – 1/03 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 40% b. Percent salary: 40% c. Role/contributions: Evaluate market definitions, market structure and performance in

the bariatric portion of the specialty hospital bed market. 1. Title: “A New Model for Assessing TB Surveillance: Action, Performance and Cost” 2. Source: Centers for Disease Control 3. Total funding: $364,000 4. Period of funding: 10/03 – 9/06 5. Principal Investigator: Peter Hilsenrath 6. a. Percent effort: 10% b. Percent salary: 10% c. Role/contributions: Direct cost and cost effectiveness analyses. XIII. Physical Facilities Office: Weber 212A XIV. Personnel Currently Supervised None XV. Theses, Professional Report and Dissertation Committees

1992 Robert Herron, Ph.D. 1993 Theresa Shireman, M.S. 1993 Lee Briggs, Ph.D. 1993 Mary Vaughan, Ph.D. 1998 Jorg Westermann, Ph.D. 1999 Tyrone Borders, Ph.D. 1999 Tso-Chiang Ma, Ph.D.

1997 Dan Culica, Ph.D. 1998 Sara Schneiders, M.S. 1999 Joe Mucherera, M.A. 2000 Ben Compton, M.P.H. 2001 Russ Gamber, M.P.H. 2003 Aravind Nemarkommula, M.P.H.

20

2003 Thaddeus Miller, M.P.H. 2003 Ronald Marcsisin, M.P.H. 2003 Tejaswi Belavadi, M.P.H. 2003 Shashank Ghantoji, M.P.H. 2003 Aravind Reddy, M.P.H. 2003 Anthony Cipriano, M.P.H. 2003 Christopher Bolton, M.P.H. 2003 Lisa Phillips, M.P.H. 2003 Donny Kalluvialayil, M.P.H. 2004 Victoria Hunt, M.P.H. 2004 Nagalla Bhanuprakash, M.P.H. 2004 Rami Hamarna, M.P.H. 2005 Emeka Ohaji, M.P.H. 2005 Zeida Rojas, M.P.H. 2006 Venkateswar Kappa, M.P.H. 2007 Shanna Brown, M.P.H. 2007 Thaddeus Miller Dr.P.H. 2007 Nyebol Madut, M.P.H. 2008 Jotam Pasipanodya, Dr.P.H.

XVI. Bibliography

A. Peer-Reviewed Journal Publications

1) Hilsenrath, P. “The Development of Synthetic Fuels in South Africa.” Journal of Energy and Development 14(2):269-283, 1989.

2) Hilsenrath, P. “Managed Care and the Reorganization of Navy Medicine.” Military Medicine 155(12): 601-604, 1990.

3) Hilsenrath, P., Smith, W., Franken E., Berbaum K. and Owen D. “Analysis of the Cost-Effectiveness of PACS.” American Journal of Roentgenology 156:177-180, January 1991.

4) Hilsenrath, P. “Monopolistic Competition and the Health Care Sector.” Health Services Management Research 4(2):82-88, 1991.

5) Hilsenrath, P., Robnett, M. and Smith W. “Assessing Hospital Radiology Productivity.”

Administrative Radiology 10(8):60-62, 1991

21

6) Hilsenrath, P. and Joseph, H. “Health Economics: Issues for South Africa.” South African Journal of Economics 59(2):146-159, 1991.

7) Hilsenrath, P., Chien, R. and Rohrer, J. “Implementing EACHs and PCHs on a Statewide Basis:

A Preliminary Analysis.” The Journal of Rural Health 7(5):618-629, 1991.

8) Hilsenrath, P. “Appropriate Care and the Market for Physician Services.” Journal of American Health Policy 1(4):49-51, 1992.

9) Fraser-Hill, M., Renfrew, D. and Hilsenrath, P. “Percutaneous Needle Biopsy of Musculoskeletal

Lesions: Cost-Effectiveness.” American Journal of Roentgenology 158:813-818, April 1992.

10) Rohrer, J.E. and Hilsenrath, P.E. “The Role of the Generalist in Health Administration Education.” Journal of Health Administration Education 10(3):479-490, 1992

11) Hilsenrath, P. “Stages of Growth Revisited.” Development Southern Africa 10(1):101-110, 1993.

12) Hilsenrath, P., Levey, S., Weil, T.P. and Ludke, R. “Health Services Management Manpower

and Educational Needs: Outlook for the Future.” Journal of Health Administration Education 11(3):407-419, 1993.

13) Strauss, R. and Hilsenrath, P. “Commentary on the Cost-Effectiveness of Preoperative

Autologous Blood Donation in Coronary Bypass Surgery.” Annals of Thoracic Surgery 57:168-169, January 1994.

14) Shireman, T. Hilsenrath, P., Strauss, R., Widness, J. and Mutnick, A. “Human Recombinant

Erythropoietin Versus Transfusions in the Treatment of Anemia of Prematurity: A Cost-Effective Analysis.” Archives of Pediatrics and Adolescent Medicine 148:582-588, June 1994.

15) Vaughan, M., Hilsenrath, P. and Ludke, R. “The Economic Impact of Hospitals on a Local

Economy: A Case Study in Iowa and Illinois.” Health Care Management Review 19(3):34-40, 1994.

16) Fain, J., Hilsenrath, P., Strauss, R., Widness, J. and Mutnick, A. “A Cost Analysis of

Erythropoietin vs. Red Blood Cell Transfusions in the Treatment of Anemia of Prematurity.” Transfusion 35(11):936-943, 1995.

17) Briggs, L., Rohrer, J., Ludke, R., Hilsenrath, P. and Phillips, K. “Geographic Variation in

Primary Care Visits in Iowa.” Health Services Research 30(5):657-671, 1995.

18) Hilsenrath, P. and Meyer, M. “Health Care Reform in South Africa: Comparisons with the United States.” Development Southern Africa 13(5):759-769, 1996.

19) Hilsenrath, P., Levey, S. and O'Neill, L. "Efficiency in Management and Economics:

Implications for Benchmarking." Best Practices and Benchmarking in Healthcare 2 (5): 208-213, 1997.

22

20) Hilsenrath, P. "Investment Opportunities and Preventive Intervention in For-Profit HMOs." Journal of Public Health Management and Practice 4 (3):73-76, 1998.

21) Levey, S., Hilsenrath, P. and Hill, J. "Dilemmas in Health Management Education: Past, Present

and Future." Journal of Health Administration Education 16 (1): 67-85, 1998.

22) Hilsenrath, P. “Fiscal Policy Dilemmas and Health Spending in South Africa.” Journal of Health and Human Services Administration 21 (3): 310-324, 1999.

23) Hilsenrath, P., Nemechek, J., Widness, J, Cordle, D. and Strauss, R. "Cost-Effectiveness of a

Limited Donor Blood Program for Neonatal RBC Transfusions" Transfusion 39 (9): 938-943, 1999.

24) Rohrer, J. and Hilsenrath, P. “Client Satisfaction with Substance Abuse Treatment” Health

Marketing Quarterly 17 (2): 31- 42, 1999.

25) Boysen, D. and Hilsenrath, P. “Antitrust and Physician Networks: Expansion of the Rule of Reason” Texas Journal of Rural Health 18 (3): 38-44, 2000.

26) Borders, T., Rohrer, J., Hilsenrath, P. and Ward, M. “Why Rural Residents Migrate for Family

Physician Care” The Journal of Rural Health 16 (4): 337-348, 2000.

27) Hilsenrath, P., Wyant, D. and Klitgaard, C. “Mobilizing Private Capital for South Africa’s Rural Health Sector” Texas Journal of Rural Health 19 (1): 28-39, 2001.

28) Coyne, J. and Hilsenrath, P. “Health System Performance in South Africa vs. France: World Health Report 2000” Safundi: The Journal of South African and American Comparative Studies 2 (1):1-9, 2001.

29) Schneiders, S, Donham, K, Hilsenrath, P, Roy, N and Thu, K. “Certified Safe Farm: Using

Health Insurance Incentives to Promote Agricultural Safety and Health” Journal of Agromedicine. 8 (1): 25-36, 2001.

30) Culica, D. Rohrer, J. Ward, M., Hilsenrath, P. and Pomrehn, P. “Medical Check-Ups: Who

Doesn’t Get Them?” American Journal of Public Health 92 (1): 88-91, 2002.

31) Coyne, J. and Hilsenrath, P. “Comparative Health Systems: The WHO Report 2000” American Journal of Public Health 92 (1): 30-34, 2002.

32) Alves-Dunkerson, J, Hilsenrath, P, Cress, G. and Widness, J. “Cost Analysis of Neonatal In-Line

Ex Vivo Point-of-Care Monitoring” American Journal of Clinical Pathology 117 (5): 809-818, 2002.

33) Hilsenrath, P., Lykens, K. and Mains, D. “Physician Supply: An Economic and Policy

Perspective” Texas Journal of Rural Health 21 (1): 16-29, 2003.

34) Nemarkommula, A., Singh, K., Lykens, K and Hilsenrath, P. “A Growing Market” Marketing Health Services Winter 23 (4):34-38, 2003.

23

35) Hilsenrath, F., Trevino, F., Singh, K., and Levey, S. “An Institutional Retrospective on South

African and American Health Sectors” Journal of the Academy of Business and Economics 2 (2):154-165, 2003.

36) Coustasse, A., Hilsenrath, P. and Silva, P. “The Case of South African and Chilean Health Systems: Comparison of Financial, Economic and Health Indicators” The Internet Journal of World Health and Societal Politics 2 (2) 2005.

37) Gamber, R., Holland, S., Russo, D., Cruser, D., and Hilsenrath, P. “A Review of Cost-

Effectiveness Studies of Osteopathic Medicine: Research Questions for the Future” Journal of the American Osteopathic Association 105 (8): 357-367, 2005.

38) Hilsenrath, P. “Health Policy as Counterterrorism: Health Services and the Palestinians” Defence

and Peace Economics 16 (5):364-374, 2005.

39) Miller, T., Hilsenrath, P., Lykens, K., McNabb, S., Moonan, P. and Weis, S. “Using Cost and Health Impacts to Prioritize the Targeted Testing of Tuberculosis in the United States” Annals of Epidemiology 16 (4):305-312, 2006.

40) Smoot, T., Hilsenrath, P. and Singh, K. “Gastric Bypass Surgery in the United States: 1998-

2002” American Journal of Public Health 96 (7): 1187-1189, 2006.

41) Hilsenrath, P. “Osteopathic Medicine in Transition: Postmortem of the Osteopathic Medical Center of Texas” Journal of the American Osteopathic Association 106 (9): 558-561, 2006.

42) Miller, T, Reading, J., Hilsenrath, P. and Weis, S. “What Are the Costs of Suspected But Not

Reported Tuberculosis?” Annals of Epidemiology 16 (10): 777-781, 2006.

43) Hilsenrath, P. and Singh, K. “Palestinian Health Institutions: Finding a Way Forward in the Wake of the Second Intifada” Peace Economics, Peace Science and Public Policy 13 (1): 1-13, 2007.

44) Buchholz, G., Coustasse, A., Hilsenrath, P. “The Chilean Pension System at 25 Years: The

Evolution of a Revolution” Journal of Economic Issues 42 (3):633-647, 2008.

45) Miller, T., Hilsenrath P., McNabb, S., Pasipanodya, J. and Weis, S. “Personal and Societal Health Quality Lost to Tuberculosis” PLoS One 4 (4) 2009: e5080.doi:10.1371/journal.pone.0005080.

46) Wilson, F., Stimpson, J. and Hilsenrath, P. “Gasoline Prices and Their Relationship With Rising Motorcycle Fatalities, 1990 – 2007” American Journal of Public Health 99 (10):1753-1758, 2009.

47) Miller, T., McNabb, S., Hilsenrath, P., Pasipandoya, J., Drewyer, G., and Weis, S. “The Societal Costs of Tuberculosis: Tarrant County, Texas 2002” Annals of Epidemiology 20 (1): 1-7, 2010.

48) Pasipanodya, J. McNabb, S., Hilsenrath, P., Bae, S., Lykens, K. Vecino, E. Munguia, G. Miller, T., Drewyer, G. and Weis, S. “Pulmonary Impairment after Tuberculosis and its Contribution to

24

TB Burden” BMC Public Health 10 (259): 2-10, 2010, http://www.biomedcentral.com/1471-2458/10/259

49) Hilsenrath, P. “Health Expenditure Efficiency: Implications for Pharmaceutical Marketing” International Journal of Pharmaceutical and Healthcare Marketing 5 (2): 118-134, 2011.

50) Hilsenrath, P. “Healthcare Management Education Settings: History and Perspective” Journal of Management History 18 (4): 386-400, 2012.

51) Hilsenrath, P, Woelfel, J. Shek, A. and Ordanza, K. “Redefining the Role of the Pharmacist: Medication Therapy Management” The Journal of Rural Health 28 (4):425-430, 2012.

52) Hilsenrath, P. and Fischer, K. “Economic Transformation in Health Care: Implications for Rural Communities” Commentary in the The Journal of Rural Health 29 (4): 337-338, 2013.

53) Coyne, J., Hilsenrath, P. Arbuckle, B. Kureshy, F. Vaughan, D. Grayson, D. and Saygin, T. “Triple Aim Program: Assessing its Effectiveness as a Hospital Management Tool” Hospital Topics 92 (4):88-95, 2014.

54) Hilsenrath, P., Eakin, C., and Fischer, K. “Price-Transparency and Cost Accounting: Challenges

for Health Care Organizations in the Consumer-Driven Era” Inquiry: The Journal of Health Care Organization, Provision, and Financing 52: 2015: 1-5.

55) Zhu, P. and Hilsenrath, P. “Mergers and Acquisitions in US Retail Pharmacy” Journal of Health Care Finance 41 (3) 2015: 1-20.

56) Zhu, H., Wilson, F., Stimpson, J., and Hilsenrath, P. “Rising Gasoline Prices Increase New Motorcycle Sales and Fatalities” Injury Epidemiology 2 (23): 1-8, 2015.

57) Broom, K. and Hilsenrath, P. “ACHE Member Survey: Perspectives on Graduate Health Management Education” Journal of Health Administration Education 32 (3) 2015: 341-358.

58) Li, H. and Hilsenrath, P. “Organization and Finance of China’s Health Sector: Historical Antecedents for Macroeconomic Structural Adjustment” Inquiry: The Journal of Health Care Organization, Provision, and Financing 53: 1-8, 2016.

59) Ouyang, W. and Hilsenrath, P. “Price Variation M&A and CAPEX in Health Care: Information Gleaned from Stock Price Variation” Inquiry: The Journal of Health Care Organization, Provision, and Financing 54: 1-7, 2017.

60) Hilsenrath, P. and Pogue, T. “Distributed Dynamic Capabilities in South Africa’s Mineral Resource-Finance Network” Technology in Society, 49 (May) 57-67, 2017.

61) Szyliowicz, D. and Hilsenrath, P. “Medical Marijuana Knowledge and Attitudes: A Survey of the California Pharmacists Association” Journal of Primary Care & Community Health 10: 1-6, January 2019.

http://www.biomedcentral.com/1471-2458/10/259

http://www.biomedcentral.com/1471-2458/10/259

25

62) Hilsenrath, P. “Ethics and Economic Growth in the Age of COVID 19: What is a Just Society to Do?” The Journal of Rural Health Early View, April 3, 2020.

63) Hilsenrath, P. and Border, T. “Ethics and Economics of the COVID-19 Pandemic in the United States” Health Services Research & Managerial Epidemiology vol.7 September 16, 2020.

B. Technical Reports, Book Chapters, Conference Proceedings and Other Publications

1) Hilsenrath, P. Economic Theory and the Optimal Depletion of Coal Reserves in South Africa.

Occasional Paper # 3, University of the Witwatersrand Press, August 1984.

2) Thompson, F., Brandt, L., Hilsenrath, P., Rehorst, D., Walne, G. and Schertler, J. Report by the Secretary of the Navy to the Secretary of Defense by Direction of the Goldwater-Nichols Department of Defense Reorganization Act of 1986. August 1987.

3) Hilsenrath, P. An Evaluation of the Navy Estimate of CHAMPUS Cost Growth. Center for Naval

Analyses Working Paper, November 1987.

4) Cook, T. and Hilsenrath, P. A Comparison of Medical Manpower Costs: Military, Civil Service and Contractor. Center for Naval Analyses Research Memorandum, No. 87-72, pp. 1-A4, May 1987.

5) Hilsenrath, P., Jondrow, J., Keller, J. and Tuxbury, B. Measures of Aircraft Reliability, Maintainability and Safety: Do They Measure “System Quality?” Center for Naval Analyses Research Memorandum, No. 87-89, pp. 1–D3, June 1987.

6) Anger, T., Berg, R., Rowen, W. (Vice ADM, US Navy Retired), Thunman, N. (Vice ADM, US Navy Retired), Hilsenrath, P., Kelly J. (Captain), Kemp, D. (Captain), Vosloh, D. (Captain) and Miller, T. (Lt. Comdr.) Medical Organization Study. Center for Naval Analyses Research Memorandum, No. 89-68, pp. 1-M5, April 1989.

7) Franken E., Smith W., Berbaum K., Owen D. and Hilsenrath P. “Planning, Expectation and Image Evaluation for PACS at The University of Iowa Hospitals and Clinics.” Proceedings of the Society of Photo-Optical Instrumentation Engineers 1234(1):236-251, 1990.

8) Hilsenrath, P., Smith, W., Franken, A., Owen, D. and Chang, P. “Cost-Effectiveness of Teleradiology for Rural Hospitals.” Applied Radiology 21(12):54-58, 1992.

9) Hilsenrath, P. and Uden-Holman, T.M. A Benefit-Cost Analysis of Publicly Funded Family Planning Services in Iowa. Center for Health Services Research, University of Iowa, March 1992.

10) Hilsenrath, P., Ludke, R. and Vaughan, M. Economic Impact of Hospital Spending in the Greater

Quad Cities. Center for Health Services Research, University of Iowa, July 1992.

11) Hilsenrath, P., Turner, K., Franken, E. and Smith W. “An Evaluation of Indirect Patient Costs in a Rural Nebraska Hospital.” Proceedings of the International Symposium on Computer and Communication Systems for Image-Guided Diagnosis and Therapy Berlin, Germany, Springer-Verlag, pp. 684-689, June 1995.

26

12) Hilsenrath, P. and Zhang, N. Economic Impact of Hospital Spending in Iowa. Iowa Hospital

Association, February 1995.

13) Hilsenrath, P. Strategic Plan for Greater Efficiency in the Private Sector. Representative Association of Medical Schemes (RAMS) Johannesburg, November 1995.

14) Hilsenrath, P. and Destigter, M. “Oligopsony, Health Insurance and Antitrust.” Medical Group Management Journal 43(2):52-58, 1996.

15) Hilsenrath, P. and Dahl, B. Cost Analysis of the VIA Blood Gas Monitor. VIA Medical Corporation, April 1999.

16) Hilsenrath, P., Wyant, D. and Klitgaard, C. “Establishing a Mutual Fund for South Africa’s Health Sector”. Proceedings of the First International Conference on Healthcare Systems for the New Millennium, Queretaro, Mexico May 2000.

17) Hilsenrath, P and Coyne, J. “Comparative Health Systems Analysis: South Africa and France in Light of the WHO Report 2000” Proceedings of the Business and Health Administration Association Annual Meeting, Chicago, pp.1-8, March 2001.

18) Hilsenrath, P. Editor, Self-Study for Accreditation. University of North Texas Health Science Center. Fort Worth, Texas. September 2001.

19) Hilsenrath, P. An Antitrust Analysis of the Specialty Bed Market: Bariatric Equipment

University of North Texas Health Science Center. Fort Worth, Texas, November 2002.

20) Coyne, J. and Hilsenrath, P. “Comparative Health Systems: Beyond the WHO Report 2000” Proceedings of the Second International Healthcare Conference: Global Engagement in Creating Financially Viable Healthcare Systems. pp. 7-12, Ankara, Turkey, July 2002.

21) Coustasse, A., Hilsenrath, P. and Silva, P. “Financial, Economic and Health Indicators: The Case of South Africa and Chile,” in Proceedings of the Third International Healthcare Conference: Global Engagement in Creating Financially Viable Healthcare Systems, pp. 143-154, Ashish Chandra, Editor, Charleston, West Virginia, October 2004.

22) Hilsenrath, P., Hill, J. and Levey, S. “Private Finance and Sustainable Growth of National Health Expenditures” Journal of Health Care Finance 30 (1):14-20, 2004.

23) Hilsenrath, P. and Wilson, F. “Osteopathic Medicine and Physician Supply in the United States” Journal of Health Care Finance 35 (1): 34-43, 2008.

24) Hilsenrath, P. “Cost-Benefit and Cost-Effectiveness Analyses” in Mullner, R. Encyclopedia of

Health Services Research, University of Illinois at Chicago and Sage Publications, May 2009.

25) Hilsenrath, P. “The MBA in Healthcare Management” in Peterson’s Competitive Edge: The Graduate Business Programs Search 2012.

27

26) Hilsenrath, P. and Fischer, K. “Healthcare Spending: Blessing or Curse?” Journal of Developing Drugs 2 (2) 2013.

27) Zhu, P. and Hilsenrath, P. “Mergers and Acquisitions in U.S. Retail Pharmacy” Journal of Health Care Finance 41 (3): 1-20, 2015.

D. Abstracts

1) Hanna, B., Fink, L., Newell, C., Hilsenrath, P., Osterhaus, J. and Smith, W. Cost-Effectiveness

Analysis of Sedation for Pediatric Procedures 78th Scientific Assembly of the Radiological Society of North America, 1992.

2) Hilsenrath, P. Vaughan, M and Ludke, R. Administrators in the Production of Rural Hospital

Services: A Preliminary Analysis Annual Meeting of the Association of University Programs in Health Administration (AUPHA), 1993.

3) Hilsenrath, P., Shireman, T., Fain, J., Widness, J., Strauss, R. and Mutnick, A. Economic Analysis of Erythropoietin in the Treatment of Anemia of Prematurity. Annual Meeting of the Association for Health Services Research, 1993.

4) Hilsenrath, P., Shireman, T., Fain, J., Widness, J., Strauss, R. and Mutnick, A. The Economics of Erythropoietin vs. Transfusions for Anemic Neonates. “Hot Topics 93 in Neonatology,” Washington, D.C., December 1993.

5) Balter, S., Hilsenrath, P. and Stapleton, J. Cost Analysis of CT vs. MRI Neuroimaging for Screening of CNS Disease in AIDS. “35th ICAAC,” San Francisco, September 1995.

6) Alves-Dunkerson, J., Hilsenrath, P., Widness, J., Cress, G. and Dahl, B. Economic Analyses of a Point-of-Care Blood Gas Monitor for Neonates. "Medical Technology at The University of Iowa," Iowa City, April 2000.

7) Hilsenrath, P. and Coyne, J. Beyond the World Health Report 2000 “Institute for Operations Research and Management Science Annual Meeting” San Jose, California, November 2002.

8) Hilsenrath, P., Trevino, F., Coyne, J., Singh, K., and Levey, S. An Institutional Retrospective on the Health Sectors of South Africa and the United States “Public Health 2003: Health Systems, Development, and Equity” Cape Town, South Africa, March 2003.

9) Hilsenrath, P. Ranking Health Systems of the World: The World Health Report 2000, Judge Institute of Management, Cambridge University, Cambridge, England, November 2003.

10) Hilsenrath, P. and Singh, K. Bariatric Hospital Beds: A Market That Grows As We Do “Joint Meeting of the Canadian Operations Research Society and the Institute for Operations Research and Management Science” Banff, Alberta, May 2004.

11) Miller, T., Hilsenrath, P., Weis, S., Moonan, P., McNabb, S. A Standardized Tool for Assessing TB Surveillance and Action Performance and Cost Atlanta, “National TB Controllers Workshop” June 2004.

12) Miller, T., Hilsenrath, P., Lykens, K., McNabb, S., Moonan, P., Weis, S. How Can the United States Prioritize the Targeted Testing of Tuberculosis? Academy of Health Annual Meeting, Boston 2005.

28

13) Miller, T., Hilsenrath, P., McNabb, S. and Weiss, S. Economic Evaluation of Tuberculosis and Control: Special Considerations “National TB Controllers Workshop” Atlanta, June 2005.

14) Hilsenrath, P. Economic Evaluation: Cost as a Yardstick to Aid County-Level Health Program Design. American Evaluation Association Conference, Toronto, October 2005.

15) Miller, T, Pasipanodaya, J, Muniga, G., Vecino, E., Hilsenrath, P. and Weis, S. Health Quality Lost to Mild Post Tuberculosis Pulmonary Impairment Annual Meeting of the National Tuberculosis Controllers Association, Atlanta, June 2006.

16) Ngo, C.M., Carr-Lopez, S. and Hilsenrath, P. Designing and Implementing Hospital-Based Advanced Practice Experiences for Dual Degree PharmD/MBA Students Midyear Clinical Meeting for the American Society of Health System Pharmacists, Anaheim California, December 2010.

17) Buchholz, G., Coustasse, A. and Hilsenrath, P. Retirement Security in Times of Financial Crisis: Can the United States Learn from Chile? Annual Meeting of the Midwest Business Administration Association, Academy of Finance, Chicago, March 2011.

18) Hilsenrath, P. Health Management Education: History and Perspectives Eighth World Congress on Health Economics, Toronto, July 2011.

19) Shek, A., Hilsenrath, P., La Mattina, C., Patel, R., Walberg, M., and Woelfel, J. Medication Therapy Management for Asthma: A Case Study in California First International Symposium on the Economics of Asthma and Asthma Care Toronto, July 2011.

20) Zhu, P. and Hilsenrath, P. Mergers and Acquisitions in Retail Pharmacy University of the Pacific Research Day, April 2014.

21) Hilsenrath, P. Precautionary Savings, Health Insurance & Macroeconomic Structural Adjustment in China. The 6th International Jerusalem Conference on Health Policy, Jerusalem, Israel, May 2016. file:///C:/Users/philsenr/Downloads/Book%20of%20Abstracts%20N.pdf

22) “Health Care and Macroeconomics: Productivity, Inflation and Monetary Policy” 13th South-Eastern European Economic Research Workshop, Tirana, Albania, December 2019.

23) “Health Care and Macroeconomics: Productivity, Inflation and Monetary Policy” Western Economic Association Annual International Meeting, Shanghai, March 2020. (conference cancelled due to coronavirus)

24) E. Book Reviews

1) Hilsenrath, P.- review of Phillips, David R. Health and Health Care in the Third World. Hospital and Health Services Administration 36(1):154-155, 1991.

2) Hilsenrath, P.- review of: Eastaugh, Steven R. Health Economics: Efficiency, Quality and Equity. Journal of Health Administration Education 11(3):489-490, 1993.

3) Hilsenrath, P.- review of: Reekie, W.D. Health-Care Options for South Africa: Lessons from the UK and the USA. The Free Market Foundation, 1995. South African Journal of Economics 64(1):140-143, 1996.

4) Hilsenrath, P.- review of: Reekie, W.D. Prescribing the Price of Pharmaceuticals. London: The Institute of Economic Affairs, 1995. South African Journal of Economics 64(1):143-145, 1996.

29

5) Hilsenrath, P.- review of Ellis, D. with contributions by Campbell, D., Crandall, B., Peters, C., Ruff, K., Seitz, K. and Udow, M. Technology and the Future of Health Care. Inquiry 37 (4):431-432, 2000/2001.

F. Newspaper, Newsletter and Magazine Contributions, Letters to Editor

1) Hilsenrath, P. “Economics in the Medical Curriculum” Iowa Medicine November p.489, 1991.

2) Hilsenrath, P. “Government Can Be More Active In Promoting Growth” Business Day (Johannesburg) September 21, 1995.

3) Hilsenrath, P. “Monetary Policy and Civil Society” Business Day (Johannesburg) November 2,

1995.

4) Hilsenrath, P. “Weakening of the Rand Should be Welcomed” Cape Times (Cape Town) February 22, 1996.

5) Hilsenrath, P. “Health Care Insurance Benefits the Rich Most” Business Day (Johannesburg)

March 19, 1996.

6) Hilsenrath, P. and Levey, S. “Put South Africa to Work: A Seven-Point Framework for South Africa” African Business April 1996.

7) Hilsenrath, P. “Classical Economic Prescriptions May Not Suit South Africa” Business Day

(Johannesburg) June 13, 1996.

8) Hilsenrath, P. “Growth, Employment and Redistribution: A Comment” Weekly Mail and Guardian June 20, 1996.

9) Hilsenrath, P. “Social Concerns Factor in U.S. Election” Business Day (Johannesburg) October

14, 1996.

10) Hilsenrath, P. and Levey, S. “South Africa Could Grow by Investing in Human Capital” Cedar Rapids Gazette, December 10, 1996.

11) Hilsenrath, P. "Your Health." Money Matters (Cape Town) September 1997.

12) Coyne, J. and Hilsenrath, P. “Coyne and Hilsenrath Respond” American Journal of Public Health 92 (7):1055, 2002.

13) Hilsenrath, P. “Health Spending in South Africa and the Washington Consensus” Safundi: The

Monthly Research Newsletter, October 2003.

14) Miller, T., Weiss, S., Moonan, P. and Hilsenrath, P. Comprehensive Cost Description of Tuberculosis Care The International Journal of Tuberculosis and Lung Disease 9 (4):467-468, 2005.

30

15) Hilsenrath, P and McNabb, S. “Conference on the Economics of TB Prevention and Control” TB Notes (internal CDC publication) Volume 1:23-24, 2006.

16) Levey, S. and Hilsenrath, P. “Counting Health Care Costs: What Presidential Candidates Say and What They Avoid Saying” Iowa City Press-Citizen December 26, 2007.

17) Hilsenrath, P. “A Possible Health-Care Trade Off” Wall Street Journal November 19, 2009.

18) Hilsenrath, P. “Washington Releases National Health Expenditure Data for 2008” The Edge – The Newsletter of the Northern California Chapter of the Healthcare Financial Management Association March 2010.

19) Hilsenrath, P. “On Salam Fayyad, South Africa and Prospects for Peace” Jerusalem Post, January 25, 2011.

20) Hilsenrath, P. “A Prescription for Controlling Health Care Costs: Federal Research Grant Reform” Huffington Post, December 11, 2012.

21) Hilsenrath, P. Letter to the Editor “Value-Based Insurance Design and Costs” Health Affairs 33

(5) 2014.

22) Hilsenrath, P. “Proposition 45: A Health Economist’s Perspective” Stockton Record, October 29, 2014.

23) Hilsenrath, P. “Healthcare Reform has Macroeconomic Implications” China Daily, May 19, 2015.

24) Hilsenrath, P. “Challenges on the Way to Better Public Health” China Daily, May 21, 2015.

25) Hilsenrath, P. “China’s Slowdown is a Sign of Middle-Class Gains, Not a Reason to Panic” published in The Conversation October 15, 2015 and republished in Fortune, Business Insider and Economy Watch: https://fortune.com/2015/10/15/china-economic-slowdown-middle-class/

26) Hilsenrath, P. and O’Neill, L. “What’s Next for Obamacare?” Thrive Global, January 5, 2017: https://thriveglobal.com/stories/what-s-next-for-obamacare/

27) Hilsenrath, P. “How an Economic Theory Helped Mire the United States in Vietnam” The Conversation, September 21, 2017. Republished in Salon : https://theconversation.com/how-an-economic-theory-helped-mire-the-united-states-in-vietnam-84403

28) Hilsenrath, P. and Wyant, D. “3 Ways Trump Could Disrupt Healthcare for the Better” The Conversation January 18, 2019. Republished in Market Watch: https://www.marketwatch.com/story/3-smart-ways-trump-can-disrupt-health-care-and-drive-down-costs-2019-01-21

29) Hilsenrath, P. and Borders, T. “COVID 19: Ethics, Economics and Pandemic Policy in the United States” The Medium July 21 2020”: https://medium.com/@philsenrath/covid-19-ethics-economics-and-pandemic-policy-in-the-united-states-185597a14f82

https://fortune.com/2015/10/15/china-economic-slowdown-middle-class/

https://thriveglobal.com/stories/what-s-next-for-obamacare/

https://theconversation.com/how-an-economic-theory-helped-mire-the-united-states-in-vietnam-84403

https://theconversation.com/how-an-economic-theory-helped-mire-the-united-states-in-vietnam-84403

https://www.marketwatch.com/story/3-smart-ways-trump-can-disrupt-health-care-and-drive-down-costs-2019-01-21

https://www.marketwatch.com/story/3-smart-ways-trump-can-disrupt-health-care-and-drive-down-costs-2019-01-21

https://medium.com/@philsenrath/covid-19-ethics-economics-and-pandemic-policy-in-the-united-states-185597a14f82

https://medium.com/@philsenrath/covid-19-ethics-economics-and-pandemic-policy-in-the-united-states-185597a14f82

31

G. Selected Presentations

1) “Assessment of CHAMPUS Costs.” Program Resources Appraisal Division of the Office of Navy Program Planning, The Pentagon, May 1987.

2) “Logistics and the Feasibility of Atlantic Fleet War Plans.” Deputy Chief of Naval Operations,

Logistics, The Pentagon, July 1988.

3) “Economics of Picture Archiving and Communications Systems.” SPIE (The International Society for Optical Engineering) Conference, Newport Beach, California, February 1990.

4) “Monopolistic Competition and the Health Care Sector.” Association of University Programs in

Health Administration (AUPHA) Annual Meeting, Chicago, Illinois, April 1990.

5) “Equity, Efficiency, and Restructuring Health Services in South Africa.” Center for Comparative and International Studies at the University of Iowa, Iowa City, IA, February 1991.

6) “Monopolistic Competition and the Health Care Sector.” Department of Ophthalmology at The

University of Iowa, Iowa City, IA, May 1991.

7) “Role of Market Mechanisms in Health Services,” Jagiellonia University, Krakow, Poland, January 1992.

8) “A Benefit-Cost Analysis of Publicly Funded Family Planning Services in Iowa.” Family

Planning Council of Iowa, Des Moines, IA, February1992.

9) “Rationing Health Care in Oregon.” Cedar Rapids Chamber of Commerce, Cedar Rapids, IA, April 1992.

10) Panelist: Forum on Socialized Medicine, College of Business Administration, University of Iowa (1992)

11) “Economic Impact of Hospital Spending in the Quad Cities.” Greater Quad City Hospital

Council, Aledo, Illinois, August 1992.

12) “Health Services Management Manpower: Outlook for the Future.” Iowa Society for Medical Technology, Des Moines, IA, April 1993.

13) “Administrators in the Production of Rural Hospital Services.” AUPHA Annual Meeting,

Atlanta, April 1993.

14) “Economic Impact of Hospital Spending: A Case Study.” AUPHA Annual Meeting, Atlanta, April 1993.

15) “Health Care Reform.” Department of Ophthalmology at The University of Iowa, Iowa City, IA,

June and August 1993.

32

16) “An Economic Analysis of Erythropoietin in the Treatment of Anemia of Prematurity.” Association of Health Services Research (AHSR) Annual Meeting, Washington D.C., June 1993.

17) “Health Care Reform: Implications for Health Care and Health Finance.” Iowa Thoracic Society,

Iowa City, IA, November 1993.

18) “Cost Effectiveness of Erythropoietin vs. Transfusions for Anemic Neonates.” Hot Topics in Neonatology, Washington D.C., December 1993.

19) “Economic Impact of Hospital Spending in Iowa.” Iowa Hospital Association, Des Moines, IA,

November 1994.

20) Panelist: Pricing to Prosper in Today’s Health Care Environment, University of Iowa, 1994.

21) “The Role of Technology in the Health Care Sector.” Ministry of Health, Kuala Lumpur, Malaysia, January 1995.

22) “An Evaluation of Indirect Patient Costs and Teleradiology in a Rural Nebraska Hospital.” 9th

International Symposium and Exhibition on Computer-Assisted Radiology, Berlin, Germany, June 1995.

23) “Health Care Reform in South Africa: Comparisons with the United States.” Biennial

Conference of the Economic Society of South Africa, Johannesburg, September 1995.

24) “Optimal Budget Deficits.” Finance Committee, Parliament of South Africa, February 1996.

25) “Health Care Markets in South Africa.” Reconstruction and Development (RDP) Committee, Parliament of South Africa, March 1996.

26) “The Currency Crisis and the State of the Economy.” Peitermaritzburg (South Africa) Chamber

of Commerce, April 1996.

27) “Health Care Markets in the United States and South Africa.” D&E Health Benefits Ltd., Cape Town, South Africa, June 1996.

28) "Economics of Health Care: Issues for the Elderly." Elderly Services Agency, Iowa City,

November 1997.

29) “Cost-Effectiveness of Single Donor Blood Supply” Association of University Programs in Health Administration (AUPHA) Annual Meeting, Washington DC, June 1998.

30) “Cost-Effectiveness of Limited Donor Blood Supply” Institute for Operations Research and

Management Science (INFORMS) Annual Meeting, Seattle, October 1998.

31) “Cost Analysis of a Point of Care Blood Gas Analyzer” Institute for Operations Research and Management Science (INFORMS) Annual Meeting, Philadelphia, November 1999.

33

32) "Establishing a Mutual Fund for South Africa's Health Sector" First International Conference on Healthcare Systems for the New Millennium, Queretaro, Mexico, May 2000.

33) "Economic Analyses of a Point-of-Care Blood Gas Monitor for Neonates." Institute for

Operations Research and Management Science (INFORMS) Annual Meeting, San Antonio, November 2000.

34) “Comparative Health Systems Performance Analysis: South Africa and France in Light of the

WHO Report 2000” Business and Health Administration Association Annual Meeting, Chicago, March 2001.

35) “Global Comparisons of Health Systems: South Africa and France” Second Hawaii International

Conference on Business, Honolulu, June 2001.

36) “Health Management Education and Global Health Sector Reform” Romanian Institute of Public Health, Bucharest, Romania, November 2001.

37) “Global Comparisons of Health Systems: The World Health Report 2000” National Postgraduate

Institute, Sofia, Bulgaria, November 2001.

38) “International Health Systems Analysis: Beyond the World Health Report 2000” Global Engagement in Creating Financially Viable Health Care Systems, Ankara, Turkey, July 2002.

39) “Physician Supply: An Economic and Policy Perspective” Rural Partnering: The Roadmap to

Success, Texas Tech University, Lubbock, Texas, September 2002.

40) “Beyond the World Health Report 2000” Institute for Operations Research and Management Science (INFORMS) Annual Meeting, San Jose, California, November 2002.

41) “An Institutional Retrospective on South African and American Health Sectors” Annual Meeting

of the International Academy of Business and Economics, Las Vegas, October 2003.

42) “Ranking Health Systems of the World: The World Health Report 2000” Judge School of Management, Cambridge University, Cambridge, United Kingdom, November 2003.

43) “Bariatric Hospital Beds: A Market That Grows As We Do” Joint Meeting of the Canadian Operations Research Society and the Institute for Operations Research and Management Science, Banff, Alberta, May 2004.

44) “A Standardized Tool for Assessing Tuberculosis Surveillance and Action Performance and Cost: Progress to June 2004” National TB Controllers Workshop, Atlanta, June 2004.

45) “Health Policy as Counterterrorism: Health Services and the Palestinians” Lisbon Conference on Defense and Security 2004, Institute of National Defense, Lisbon, Portugal, July 2004.

46) “Cost and Cost-Effectiveness of Tuberculosis Surveillance, Action and Support: Florida and Texas Models” The Surveillance, Epidemiology and Outbreak Investigations Branch, Division of Tuberculosis Elimination, Centers for Disease Control, Atlanta, July 2004.

34

47) “Economic Aspects of Counterterrorism: Palestinian Health Infrastructure” Battelle Memorial Laboratories, Arlington, Virginia, December 2004.

48) “Gastric Bypass Surgery in the United States” Fifth Hawaii International Conference on Business, Honolulu, May 2005.

49) “Private Finance and Sustainable Growth of National Health Expenditures” Department of Health Management and Policy, Peking University, Beijing China, May 2005.

50) “The Private Finance of Health Spending and Economic Institutions” Shandong Institute of Finance, Jinan, China, May 2005.

51) “Cost as a Yardstick to Aid County Level Health Program Design” Joint Conference of the Canadian and American Evaluation Associations Toronto, October 2005.

52) “Hamas, Palestinian Health Care Institutions and Global Security Considerations” University of Arkansas School of Public Health at Little Rock, October 2006

53) “Physician Supply: Challenges for Health Management” University of the Pacific College of Business Administration, Stockton, California, February 2008.

54) “Doctors of Osteopathic Medicine and Physician Supply” College of Public Health, University of Georgia, April 2008.

55) “How Better Palestinian Health Care Institutions Can Promote Peace” Technical University of Berlin, May 2008.

56) “Gasoline Prices, Motorcycle Use and Motorcycle Fatalities” 7th World Congress on Health Economics, International Health Economics Association, Beijing China July 2009.

57) Discussant, Annual Meeting of the Academy of Management, Chicago 2009, “Finance, Efficiency and Performance in Health Care Organizations

58) “Health Care Reform” Fairfield Bay Rotary Club, Fairfield Bay, Arkansas, August 2009.

59) Health Management Education: The MBA vs. MHA, Annual Meeting of the Association of Marketing and Health Care Research, South Lake Tahoe, Nevada, February 2010.

60) “Health Insurance Reform and National Health Expenditures” North Stockton Rotary Club, Stockton, California, April 2010.

61) “US Healthcare Reform: Marketing Global Pharmaceuticals” Sixth International Conference on Health Care Systems, Zirve University, Gaziantep, Turkey, October 2010.

62) “Graduate Healthcare Management Education: Origins and Development” Association of University Programs in Health Administration Leaders Conference, Chicago, March 2011.

63) “Retirement Security in Times of Financial Crisis: Lessons for the United States from Chile” Midwest Business Administration Association (MBAA) Annual Meeting, Chicago, March 2011.

64) “Graduate Healthcare Management Education: History and Perspectives” University of Arkansas for Medical Sciences” Little Rock, June 2011.

65) “Medication Therapy Management for Asthma” First International Symposium on the Economics of Asthma and Asthma Care, Toronto, July 2011.

35

66) “Health Management Education: History and Institutional Perspectives” Eighth World Congress on Health Economics, Toronto, July 2011.

67) “National Health Expenditures: Efficiency and Sustainability” Weber Point Coffee Club” University of the Pacific, Stockton California, September 2011.

68) Panelist, Cost Efficiency and Cost Containment: Creating a Culture of Efficiency in Production and Distribution of Healthcare offered by the California Association of Healthcare Leaders (part of the ACHE) at the University of the Pacific, Stockton, California, April 2012.

69) “Origins of Leading Sector Technology in South Africa: Coal-Based Synthetic Fuels and Cyanide-Based Gold Extraction” XVIth World Economic History Congress, Stellenbosch, South Africa, July 2012.

70) “Healthcare Occupations Outlook in the USA” Seventh International Conference on Healthcare Systems & Global Business Issues, Jaipur National University, Jaipur, India, January 2013.

71) Panelist “Best Practices in Business Schools – What Should the Future of Business Education Look Like to Enhance Student Skills” Seventh International Conference on Healthcare Systems & Global Business Issues, Jaipur National University, Jaipur, India, January 2013.

72) Reactor: “Global Models of Strategic Management: The Triple Aim Program” Association of University Programs in Health Administration (AUPHA) Pre-Conference Symposium, Monterey, California, June 2013.

73) Panelist: “Global Models of Strategic Management: Building Successful Global Health Management Education Programs” Association of University Programs in Health Administration (AUPHA) Pre-Conference Symposium, Monterey, California, June 2013.

74) “The Triple Aim Program with Special Reference to Economics, Culture and Education” 33rd Annual Association for Marketing & Health Services Research Conference, Telluride, Colorado, February 2014.

75) Discussant “Developing Global Health Management Competencies and Capacity in Saudi Arabia” AUPHA Global Health Pre-Conference Symposium, San Antonio, Texas, June 2014.

76) Discussant “An Evidence Based Competencies and Skills Framework for Programs in Health Service Management” AUPHA Global Health Pre-Conference Symposium, San Antonio, Texas, June 2014.

77) Panelist “Health Management Education Opportunities in China” AUPHA Global Health Pre-Conference Symposium, San Antonio, Texas, June 2014.

78) “Mergers and Acquisitions in U.S. Retail Pharmacy” 13th Annual International Conference on Health Economics, Management and Policy, Athens, Greece, June 2014.

79) “Methodological Issues in Mergers & Acquisitions Research in Retail Pharmacy” Comprehensive Cancer Center Biostatistics and Bioinformatics Shared Facility, Division of Preventive Medicine, University of Alabama College of Medicine, Birmingham, November 2014.

80) “The MBA vs. MHA: Survey of American College of Healthcare Executives (ACHE)” Shandong University Center for Health Management and Policy, Jinan, China, April 2015.

36

81) “Obamacare: Health Insurance Reform in the United States” Shandong University Center for Health Management and Policy, Jinan, China, April 2015.

82) “Health Policy as Counterterrorism: Hamas and the Palestinians” Shandong University Center for Health Management and Policy, Jinan, China, May 2015.

83) “Marketing of Pharmaceuticals” Shandong University Center for Health Management and Policy, Jinan, China, May 2015.

84) “Mergers and Acquisitions in US Retail Pharmacy” Shandong University Center for Health Management and Policy, Jinan, China, May 2015.

85) “South Africa’s Natural Resource-Based Economy: Technology, Capabilities, and Path Dependency” Pacific World History Institute Meeting, San Francisco, May 2016.

86) “Precautionary Savings: Health Insurance & Macroeconomic Structural Adjustment in China” The 6th International Jerusalem Conference on Health Policy, Jerusalem, May 2016.

87) “A Fraught Public-Private Partnership and the Evolution of Health Services in China” AUPHA Global Health Pre-Conference Symposium, Kansas City, June 2016.

88) “Reflections on Samuel Levey: Scholar, Mentor and Pioneer” 38th Annual Samuel Levey Healthcare Leadership Symposium Reception, Iowa City, September 2016.

89) “Finance: Overview for American College of Healthcare Executives Board of Governors Exam” Kaiser Permanente, Vacaville, California, March 2017.

90) “Path Dependency, Capabilities and the Evolution of South Africa’s Natural Resource–Based Economy” The 2017 Meeting of the Business History Conference, Denver, April 2017.

91) “Corporate Practice of Medicine Law in the USA: Anachronism in an Age of Disruption” Asia Pacific Conference on Management and Business Hong Kong, July 2017. (Also Session Chair)

92) California’s Healthcare Environment: Challenges and Opportunities, California Dental Association, Sacramento, June 2018

93) “Pathway Dependence and Distributed Dynamic Capabilities in South Africa’s Mining-Finance Network” Tshwane Institute of Technology, Pretoria, South Africa, June 2018.

94) “Pathway Dependence and Distributed Dynamic Capabilities in South Africa’s Mining-Finance Network” Mapungubwe Institute for Strategic Reflection (MISTRA), Woodmead, Johannesburg, South Africa, June 2018.

95) “Information Technology and Transformation of American Healthcare” Fourth International Conference on Medical Ethics Continuing Education, Healthcare Systems & Global Business Issues at Sea, University at Sea, July 2018.

96) “Medical Marijuana Knowledge and Attitudes: A Survey of California Pharmacists”, UC Davis Center for Healthcare Policy and Research, Sacramento, December 2018.

97) “Rise of the Health Sector in the United States and Attendant Redistribution of Income” Annual Business History Conference, Cartagena Columbia, March 2019.

37

98) “Economics of Value-Based Pricing” Changing Regulation of Pharmaceuticals: Issues in Pricing, Intellectual Property, Trade and Ethics Conference, McGeorge School of Law, University of the Pacific, April 2019.

99) “Redistribution of Income & Wealth: Rise of US Health Care” Distinguished Speaker, Lewis College of Business, Marshall University, Huntington, West Virginia, April 2019

100) “Medical Marijuana Knowledge and Attitudes: A Survey of the California Pharmacists Association” California Pharmacists Association, Sacramento, September 2019.

101) “Health Care and Macroeconomics: Productivity, Inflation and Monetary Policy” 13th South-Eastern European Economic Research Workshop, Tirana, Albania, December 2019.

H. Selected Grant Activity

Review Committee Member for Rural Health Research Center Cooperative Agreement Program, Health Resources and Services Administration (HRSA), Department of Health and Human Services, Rockville, Maryland, June 2012. Reviewer on Objective Review Committee for US Department of Health and Human Services, Centers for Medicare and Medicaid Services for the Cooperative Agreements to Support Establishment of State-Operated Health Insurance Exchanges, District of Columbia and Idaho, May – August 2013 (proposals exceeded $100 million). Reviewer on Objective Review Committee for US Department of Health and Human Services, Centers for Medicare and Medicaid Services for the Cooperative Agreements to Support Establishment of State-Operated Health Insurance Exchanges, Virginia, August-September 2014 (proposal of approximately $10 million). University of the Pacific Travel/Small Project Grant (CAPD), $1,500, January 2015. University of the Pacific, Pacific Fund Grant, $2,620, awarded April 2014 and used first half of 2015.

I. Dissertation

Coal-Based Synthetic Fuels: The South African Experience, University of Texas at Austin, 1985.

Documents

PETER E. H ILSENRATH